Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase - Test2 - elhamkhani - TriplyDB

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

http://www.wikidata.org/entity/Q28204166

about

sameAs

TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu Apoptosis induced by the Tibetan herbal remedy PADMA 28 in the T cell-derived lymphocytic leukaemia cell line CEM-C7H2 The physiological action of picolinic Acid in the human brain The role of vascular cell adhesion molecule-1 in tumor immune evasion Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells On evolutionary origin of cancer T cell avidity and tumor recognition: implications and therapeutic strategies.Clinical significance of T cell metabolic reprogramming in cancer Immune Mechanisms in Myelodysplastic Syndrome Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?Metabolic communication in tumors: a new layer of immunoregulation for immune evasion Endotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for Immunoparalysis T Cells and Cancer: How Metabolism Shapes Immunity Advances in immunotherapy for melanoma Novel cancer antigens for personalized immunotherapies: latest evidence and clinical potential Novel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)Understanding the role of the kynurenine pathway in human breast cancer immunobiology Targeting amino acid metabolism in cancer growth and anti-tumor immune response Targeting the indoleamine 2,3-dioxygenase pathway in cancer Radio-Immunotherapy-Induced Immunogenic Cancer Cells as Basis for Induction of Systemic Anti-Tumor Immune Responses - Pre-Clinical Evidence and Ongoing Clinical Applications The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites T cell metabolism drives immunity Host-pathogen interactions between the human innate immune system and Candida albicans-understanding and modeling defense and evasion strategies Implication of indolamine 2,3 dioxygenase in the tolerance toward fetuses, tumors, and allografts The role of IDO in brain tumor immunotherapy Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity From tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumors Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?Novel immunotherapies for hematologic malignancies Trial watch: IDO inhibitors in cancer therapy The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment Molecular pathways: not a simple tube--the many functions of blood vessels Indoleamine 2,3 dioxygenase in intestinal disease Cancer immunotherapy Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase

P2860

Q21131200-1FCCBAAB-E995-4795-ACD7-DE29C98A64C0 Q21245649-FB190BE4-ECDA-4478-B960-DFCE0C8295CA Q24634995-281B982E-775C-4155-93C7-C2EEEC6BCB92 Q24635847-6FCD56D3-B132-4298-B91C-C9545CB85D29 Q24802970-9E68DB86-7AD2-4E0A-A27B-B62195C66809 Q24803579-AA00AA8E-3F65-465E-9C43-1DDB63C98299 Q24815775-5E0FB372-96B4-42E2-A9C6-604EAD33EA28 Q26741974-2835D3EB-5DC8-4AF0-AAB8-E2AC1936D347 Q26744500-99119487-4480-428D-8A1E-118F0EADA6C2 Q26745898-760D3C44-A0E2-4867-8770-ECA662994CDB Q26746104-F22D369E-41EF-425E-8FBB-015D5797C9EF Q26765256-8BB0E193-AE40-4B77-82AD-096FAE6E3297 Q26765777-B6183E64-A102-44F0-8495-7694946139A4 Q26766427-6C90D1D6-7680-4FDF-B68B-25533B4C5926 Q26768558-B6D81BCD-B045-4572-B1AE-247792017D93 Q26769884-2D125178-951C-49D6-B1F9-D33D59D075E3 Q26770391-451D46E4-2633-4D8A-B837-C8744C60B6FB Q26773472-6FD73CCE-288E-4224-8E53-2524A88CA646 Q26775425-AC6A2171-CD23-4EBD-8EE6-BFFAC7A9EB36 Q26775471-FFF3447A-4885-4E44-8397-A6573056CEEE Q26779221-E4F0B0D1-F8C5-4658-BDD1-00B3256BE958 Q26785900-B21564B8-6383-43A4-AAC5-75CBD1CC511E Q26798402-EAF52354-0692-43E2-AA55-3FDA11CA37AC Q26799575-FA25D7A9-A5C7-4C7C-82B7-63E751155CAE Q26801655-A474AB09-0E5C-4DD0-BB15-5AF15FCB9860 Q26825202-698BD426-768C-4BC2-8FCE-44ECD70ED51A Q26830399-EF1E3906-D487-4881-8DF4-029CA7774533 Q26850218-DEE26673-E1BF-4969-BB51-431B3FE5595E Q26862220-2FA5EAF8-E0F4-4A81-8E2B-CDF13DD3F686 Q26865532-CC39A3DA-95BC-4581-9BA1-C91E68C0DFD2 Q26996330-D49AE461-D67E-44ED-812B-A62A8D44F947 Q27000087-EF567E4A-A92B-4A38-9421-91D83F99A464 Q27003955-F6EE1603-A1B1-4D7C-AE02-BC21254C4FA2 Q27004436-1A95E801-E4C3-444F-AA03-31AC0DE0D42E Q27006866-2E4256A5-CE07-4FA2-8E77-08F4DC14BFDC Q27022789-32E80F17-EBB4-4F3F-B449-D78CF1E46BEF Q27025036-4A474A20-9AB0-42AC-A73B-FD5F7FD08B34 Q27025063-BEBCF38E-BF7D-4F12-B0C5-8A9A56181F08 Q27026870-F00D62FC-2A0F-47CB-8288-60DDD6FC5B6A Q27641013-62CE2DAA-BB39-4D96-A91E-76554CDF7735

P2860

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

http://www.wikidata.org/entity/Q28204166

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Evidence for a tumoral immune ...... by indoleamine 2,3-dioxygenase

@ast

Evidence for a tumoral immune ...... by indoleamine 2,3-dioxygenase

@en

Evidence for a tumoral immune ...... by indoleamine 2,3-dioxygenase

@nl

type

label

Evidence for a tumoral immune ...... by indoleamine 2,3-dioxygenase

@ast

Evidence for a tumoral immune ...... by indoleamine 2,3-dioxygenase

@en

Evidence for a tumoral immune ...... by indoleamine 2,3-dioxygenase

@nl

prefLabel

Evidence for a tumoral immune ...... by indoleamine 2,3-dioxygenase

@ast

Evidence for a tumoral immune ...... by indoleamine 2,3-dioxygenase

@en

Evidence for a tumoral immune ...... by indoleamine 2,3-dioxygenase

@nl

P1433

Q28204166-61AE3692-2515-4F27-AC6C-C802F105E9B1

P1476

Q28204166-134EC5F5-9F50-44B5-A987-29D66CE44AC7

P2093

Q28204166-18680C3D-230E-4A2A-BF2B-53D9D0C286AD

Q28204166-35A0A4A7-64F8-4E04-ACD2-37A6B5E19E4A

Q28204166-4D02F111-86C6-427A-B5F7-AA57C7F0F359

Q28204166-7FA11F3F-5B8E-4886-81F2-81285F41A395

Q28204166-8FE0D04E-80CB-44F6-9107-B83AE7C9B7F8

Q28204166-B130C3EC-7E32-4CB7-80D6-76ECD258DD83

Q28204166-B9AAF044-FA6E-40FD-9C71-CC74FD2F99EF

Q28204166-DC51655C-53D2-4612-ACF9-3002E49CB9C7

P2888

Q28204166-ECBE2490-5C69-49DC-8B03-F82A25C08A0B

P304

Q28204166-30AA2387-52C3-4EA8-91EF-1AA2EF76D847

P31

Q28204166-984FC698-A45F-4A41-AB84-4E09E3A39C3F

P3181

Q28204166-93166438-D5E5-4C4F-BD0E-166C53AD98E4

P356

Q28204166-4FDB4EDC-4045-4395-B34D-A7F0A8034AE1

P407

Q28204166-4E149851-2A52-4B0F-8579-2CB1DDB8F776

P433

Q28204166-11587801-0515-45E5-A540-D6AC473171E2

P478

Q28204166-471B2773-150B-4EC0-A0C3-B8A74BB09E5B

P577

Q28204166-1529421F-1AB3-4E8B-9EF9-7336124DC47D

P5875

Q28204166-1467EAF7-ECD1-47EB-955D-3E93C40A8FB5

P698

Q28204166-0BF4202B-BA4B-49A6-8378-17920297CAE4

P3181

P356

P1433

Nature Medicine

P1476

Evidence for a tumoral immune ...... by indoleamine 2,3-dioxygenase

@en

P2093

Benoît J Van den Eynde

http://www.w3.org/2001/XMLSchema#string

Catherine Uyttenhove

http://www.w3.org/2001/XMLSchema#string

Didier Colau

http://www.w3.org/2001/XMLSchema#string

Ivan Théate

http://www.w3.org/2001/XMLSchema#string

Luc Pilotte

http://www.w3.org/2001/XMLSchema#string

Nicolas Parmentier

http://www.w3.org/2001/XMLSchema#string

Thierry Boon

http://www.w3.org/2001/XMLSchema#string

Vincent Stroobant

http://www.w3.org/2001/XMLSchema#string

P2888

P304

1269-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

692579

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NM934

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9087249

http://www.w3.org/2001/XMLSchema#string

P698

14502282

http://www.w3.org/2001/XMLSchema#string